Sutro Biopharma Announces Pricing of $110.0 million Underwritten Offering
Sutro Biopharma, Inc. (NASDAQ:STRO) has caught the attention of institutional investors who hold a sizeable 41% stake [Yahoo! Finance]
Sutro Biopharma (NASDAQ:STRO) was upgraded by analysts at Citizens Jmp from a "market perform" rating to a "market outperform" rating. They now have a $23.00 price target on the stock.
Sutro Biopharma (NASDAQ:STRO) was upgraded by analysts at Citigroup Inc. to an "outperform" rating.
Sutro Biopharma to Present at the 44th Annual J.P. Morgan Healthcare Conference